Introduction: Paediatric patients (individuals below 18 years of age) requiring cranial‐spinal irradiation (CSI) at our institution are commonly planned and treated using a three isocentre (3‐ISO) volumetric modulated arc therapy (VMAT) technique. A modified two isocentre (2‐ISO) VMAT technique was investigated with the aim to improve workflow and reduce planning and treatment time.Methods: Five CSI paediatric patients previously treated with a 3‐ISO VMAT technique were retrospectively replanned using a 2‐ISO VMAT technique. The 2‐ISO VMAT plans were reviewed and approved by a radiation oncologist (RO) before undergoing patient‐specific quality assurance (QA) procedures, performed by a radiation oncology medical physicist (ROMP). Planning target volume (PTV) coverage, organ‐at‐risk (OAR) dose as well as planning and treatment durations of the first five patients utilising 2‐ISO technique were compared with 3‐ISO technique.Results: The average percentage difference in PTV coverage by 95% reference dose between the 2‐ISO and 3‐ISO is 0.14%, and the average difference in OAR median dose is 0.68 Gy. Conformity and homogeneity indices have the same averages at 1.18 and 0.4 respectively. Patient‐specific physics QA results were all comparable with the 3‐ISO averages at 98.84% and the 2‐ISO at 98.71%. Planning duration for the 2‐ISO was reduced by up to 75%, and daily treatment duration was reduced by up to 50%. Of all the previously treated CSI patients using a 3‐ISO technique, 45% were suitable for the 2‐ISO technique.Conclusion: The 2‐ISO VMAT technique provided comparable dose distribution based on PTV coverage, OAR dose and plan metric indices. Reduced planning and treatment duration with the 2‐ISO technique facilitated improved workflow with decreased sedation time for paediatric patients requiring a general anaesthesia.
17 August 2014 in Australasian Physics & Engineering Sciences in Medicine
There is large variability in patient specific quality assurance (PSQA) devices, techniques and protocols used clinically in radiotherapy. The SEAFARER methodology enables centres to evaluate their PSQA system's ability to detect intentionally introduced errors and compare their findings with community results. This study assessed the performance of PSQA systems in detecting simulated delivery errors for a head and neck radiotherapy case. A commercial dose-mimicking algorithm was employed to create plans of similar quality and robustness for common linac models based on an established plan. Using Python scripting, eleven copies of these plans were created and modified to simulate different delivery errors which were classified based on their dosimetric impact as 'should-pass' or 'should-fail'. Participating centres were asked to use their clinical PSQA methodologies to determine which of the modified plans passed their PSQA processes when compared to the unmodified plan's dose prediction. Eighty-nine submissions were received from 44 centres. Using their clinical PSQA systems, 48% (21/44) of centres passed at least one 'should-fail' plan. Overall sensitivity and specificity across all devices were 79% and 82%, respectively. Multiple centres reported a review or change of their PSQA protocol. Five common PSQA devices (used for 5+ submissions) were included in a comparison. Sensitivities ranged 0-100%, with every common device having at least one perfect score of 100% sensitivity and 100% specificity. Sensitivity and specificity of PSQA systems varied greatly between centres. User choices rather than inherent characteristics determine the performance of common PSQA devices.
14 February 2026 in Journal of Medical Imaging and Radiation Oncology